NCT04394130View on ClinicalTrials.gov

Analgesic Efficacy of Continuous Infusion of Local Anaesthetic Versus Single-shot Injection Interscalene Block

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 12, 2020

Primary Completion Date

August 31, 2022

Study Completion Date

September 30, 2022

Conditions
Analgesia
Interventions
DRUG

ropivacaine 0.2%

continuous peripheral nerve local anesthetic infusion (ropivacaïne 0.2 %) for 48 hours postoperative.

Trial Locations (1)

1011

CHUV, Lausanne

All Listed Sponsors
lead

Eric Albrecht

OTHER

NCT04394130 - Analgesic Efficacy of Continuous Infusion of Local Anaesthetic Versus Single-shot Injection Interscalene Block | Biotech Hunter | Biotech Hunter